These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32757991)

  • 1.
    Alalawi M; Aljahdali S; Alharbi B; Fagih L; Fatani R; Aljuhani O
    Ann Saudi Med; 2020; 40(4):305-309. PubMed ID: 32757991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of Clostridium difficile infection in patients receiving high-risk antibiotics with or without a proton pump inhibitor.
    Gordon D; Young LR; Reddy S; Bergman C; Young JD
    J Hosp Infect; 2016 Feb; 92(2):173-7. PubMed ID: 26616410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies.
    Dial S; Alrasadi K; Manoukian C; Huang A; Menzies D
    CMAJ; 2004 Jul; 171(1):33-8. PubMed ID: 15238493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of Clostridium difficile associated diarrhoea in a tertiary care hospital.
    Kaneria MV; Paul S
    J Assoc Physicians India; 2012 Nov; 60():26-8. PubMed ID: 23767199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clostridioides difficile infection: Incidence and risk factors in a tertiary care facility in Riyadh, Saudi Arabia.
    Alzouby S; Baig K; Alrabiah F; Shibl A; Al-Nakhli D; Senok AC
    J Infect Public Health; 2020 Jul; 13(7):1012-1017. PubMed ID: 31831398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton pump inhibitors and diarrhoea related to Clostridium difficile infection in hospitalised patients: a case-control study.
    Leonard AD; Ho KM; Flexman J
    Intern Med J; 2012 May; 42(5):591-4. PubMed ID: 22616966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hospital-acquired Clostridium difficile infection among patients with type 2 diabetes mellitus in acute medical wards.
    Hassan SA; Rahman RA; Huda N; Wan Bebakar WM; Lee YY
    J R Coll Physicians Edinb; 2013; 43(2):103-7. PubMed ID: 23734349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence, risk factors, and complications of Clostridium difficile infection in a tertiary care center, western region, Saudi Arabia.
    Althaqafi A; Munshi A; Baghlaf B; Munshi E; Malakah M; Almarhabi H; Alharbi M; Alsaedi A
    J Infect Public Health; 2022 Oct; 15(10):1037-1042. PubMed ID: 36041381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton Pump Inhibitors Do Not Increase Risk for Clostridium difficile Infection in the Intensive Care Unit.
    Faleck DM; Salmasian H; Furuya EY; Larson EL; Abrams JA; Freedberg DE
    Am J Gastroenterol; 2016 Nov; 111(11):1641-1648. PubMed ID: 27575714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton-pump inhibitors and the risk of Clostridium difficile-associated diarrhea in high-risk antibiotics users: A population-based case-crossover study.
    Hong SH; Lee EK; Shin JY
    Pharmacoepidemiol Drug Saf; 2019 Apr; 28(4):479-488. PubMed ID: 30848536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of suspected Clostridium difficile-associated hospital-acquired diarrhea in hospitalized patients at Siriraj Hospital.
    Thipmontree W; Kiratisin P; Manatsathit S; Thamlikitkul V
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S207-16. PubMed ID: 21721449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of Global Strategies to Prevent Hospital-Onset Clostridium difficile Infection: Targeting Proton Pump Inhibitors and Probiotics.
    Lewis PO; Lundberg TS; Tharp JL; Runnels CW
    Ann Pharmacother; 2017 Oct; 51(10):848-854. PubMed ID: 28821215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hospital ward antibiotic prescribing and the risks of Clostridium difficile infection.
    Brown K; Valenta K; Fisman D; Simor A; Daneman N
    JAMA Intern Med; 2015 Apr; 175(4):626-33. PubMed ID: 25705994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Characteristics of Clostridium difficile infection in a high complexity hospital and report of the circulation of the NAP1/027 hypervirulent strain in Colombia].
    Gualtero SM; Abril LA; Camelo N; Sanchez SD; Davila FA; Arias G; Silva E; Bustos IG; Josa DF; Torres IC; Zambrano LC; Pareja MJ
    Biomedica; 2017 Dec; 37(4):466-472. PubMed ID: 29373767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection.
    Howell MD; Novack V; Grgurich P; Soulliard D; Novack L; Pencina M; Talmor D
    Arch Intern Med; 2010 May; 170(9):784-90. PubMed ID: 20458086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastric acid suppression by proton pump inhibitors as a risk factor for clostridium difficile-associated diarrhea in hospitalized patients.
    Aseeri M; Schroeder T; Kramer J; Zackula R
    Am J Gastroenterol; 2008 Sep; 103(9):2308-13. PubMed ID: 18702653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The evaluation of Clostridium difficile infection (CDI) in a community hospital.
    Daniel A; Rapose A
    J Infect Public Health; 2015; 8(2):155-60. PubMed ID: 25301221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clostridium difficile infection and proton pump inhibitors.
    Pohl JF
    Curr Opin Pediatr; 2012 Oct; 24(5):627-31. PubMed ID: 22781139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Underlying disease severity as a major risk factor for nosocomial Clostridium difficile diarrhea.
    Kyne L; Sougioultzis S; McFarland LV; Kelly CP
    Infect Control Hosp Epidemiol; 2002 Nov; 23(11):653-9. PubMed ID: 12452292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of community-onset Clostridium difficile infection in a community in the South of England.
    Fellmeth G; Yarlagadda S; Iyer S
    J Infect Public Health; 2010; 3(3):118-23. PubMed ID: 20869672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.